tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
US Market
ENTA
Enanta Pharmaceuticals
RESEARCH TOOLSreports
Want to see ENTA full AI Analyst Report?

Enanta Pharmaceuticals (ENTA) Income Statement

190 Followers

Enanta Pharmaceuticals Income Statement

Last quarter (Q1 2026), Enanta Pharmaceuticals's total revenue was $18.61M, an increase of 9.76% from the same quarter last year. In Q1, Enanta Pharmaceuticals's net income was $-11.94M. See Enanta Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
$ 65.32M$ 67.64M$ 79.20M$ 86.16M$ 97.07M
Gross Profit
$ 60.74M$ 67.64M$ 79.20M$ 86.16M$ 97.07M
Operating Expenses
$ 146.09M$ 189.33M$ 216.41M$ 210.00M$ 206.65M
Depreciation and Amortization
$ 5.09M$ 2.34M$ 2.37M$ 2.97M$ 3.33M
EBITDA
$ -70.78M$ -104.51M$ -123.48M$ -119.22M$ -104.25M
Operating Income
$ -85.35M$ -121.69M$ -137.21M$ -123.84M$ -109.57M
Other Income/Expenses
$ 1.80M$ 3.90M$ 6.21M$ 1.66M$ 1.99M
Pretax Income
$ -83.55M$ -117.79M$ -131.00M$ -122.19M$ -107.58M
Net Income
$ -81.89M$ -116.05M$ -133.82M$ -121.75M$ -79.00M
Per Share Metrics
Basic EPS
$ -3.84$ -5.48$ -6.38$ -5.91$ -3.92
Diluted EPS
$ -3.84$ -5.48$ -6.38$ -5.91$ -3.92
Weighted Average Shares Outstanding
 21.34M 21.16M 20.97M 20.60M 20.17M
Weighted Average Shares Outstanding (Diluted)
 21.34M 21.16M 20.97M 20.60M 20.17M
Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History